A Review of Switching Strategies for Patients with Schizophrenia Comorbid with Metabolic Syndrome or Metabolic Abnormalities
Sign Up to like & getrecommendations! Published in 2021 at "Neuropsychiatric Disease and Treatment"
DOI: 10.2147/ndt.s294521
Abstract: Abstract Metabolic syndrome (MetS) in patients with schizophrenia occurs 2–3 times more frequently than in the general population. Antipsychotic medication is a primary risk factor for patients with MetS. In particular, the widely used second-generation… read more here.
Keywords: metabolic syndrome; metabolic abnormalities; strategies patients; review switching ... See more keywords